Medical Properties Trust, Inc. reported second-quarter 2026 total revenues of $259.3 million, up from $240.4 million a year earlier, driven primarily by higher rent billed. The company recorded a net loss of $2.6 million (‑$0.01 per share), a substantial improvement from a $98.4 million loss (‑$0.16 per share) in the prior-year quarter. Normalized funds from operations (NFFO) were $92.2 million, or $0.15 per share, compared with $81.4 million, or $0.14 per share, reflecting better underlying operating performance despite ongoing impairments and high interest costs.
As of June 30 2026, Medical Properties Trust had total assets of $14.7 billion and a portfolio of 373 properties with approximately 38,000 licensed beds across the U.S. and eight other countries. Net investment in real estate assets was $10.9 billion. Debt, net totaled $9.7 billion, with adjusted net debt to annualized EBITDAre at 8.9x and an adjusted interest coverage ratio of 1.9x, highlighting a still-leveraged balance sheet.
Subsequent to quarter end, the company agreed to a major refinancing in which its operating partnership will issue $2.4 billion of new 9.25% senior secured notes due 2032 through a new-money private placement and private exchange. The transaction is expected to refinance multiple unsecured note maturities, reduce total principal debt by approximately $123 million to $9.5 billion, and leave only $1.3 billion of unsecured note maturities through 2028, materially extending the debt maturity profile.
MEDICAL PROPERTIES TRUST INC executive Charles R. Lambert, SVP of Finance and Treasurer, reported a routine tax-related share withholding. The company withheld 2,347 shares of common stock at $4.61 per share when restricted stock vested to cover tax obligations.
After this non-market transaction, Lambert directly holds 387,707 shares of common stock. The footnote clarifies this withholding does not constitute a sale in the open market.
Medical Properties Trust senior vice president and senior advisor to the CEO, Larry H. Portal, reported a routine tax-related share disposition. On the vesting of restricted stock, 4,048 shares of common stock were withheld at $4.61 per share to satisfy tax withholding obligations, as noted in the footnote that this does not constitute a sale transaction. After this tax withholding, Portal directly holds 575,028 shares of Medical Properties Trust common stock.
MEDICAL PROPERTIES TRUST INC Chairman, President & CEO Edward K. Aldag Jr. reported a compensation-related share withholding. A total of 109,433 shares of common stock were withheld at $4.61 per share upon vesting of restricted stock to satisfy tax withholding obligations, and this is explicitly described as not constituting a sale transaction. Following this tax-withholding disposition, he directly holds 6,685,775 shares of the company’s common stock.
MEDICAL PROPERTIES TRUST INC Executive Vice President & CFO R. Steven Hamner reported a routine tax-related share disposition. A total of 48,548 shares of common stock were withheld upon the vesting of restricted stock to cover tax obligations at $4.61 per share. This was not an open-market sale, and Hamner continues to hold 3,792,472 shares directly after the transaction.
MEDICAL PROPERTIES TRUST INC insider James Kevin Hanna reported a routine tax-related share disposition. Upon vesting of restricted stock, 3,295 common shares were withheld to satisfy tax withholding obligations at a reference price of $4.61 per share, which the footnote clarifies is not an open-market sale. After this non-market transaction, Hanna directly holds 540,204 common shares.
MEDICAL PROPERTIES TRUST INC senior vice president of operations Rosa Handley reported a routine tax-related share disposition. The company withheld 1,938 shares of common stock at $4.61 per share to cover tax obligations upon vesting of restricted stock, leaving her with 448,898 directly held shares. The filing clarifies this was not an open-market sale.
Medical Properties Trust, Inc. reported results of its annual stockholder meeting held on May 28, 2026. As of the March 19, 2026 record date, 602,829,003 shares of common stock were outstanding and entitled to vote, and 468,686,557 shares were represented, establishing a quorum.
Stockholders elected nine directors to serve until the 2027 annual meeting or until their successors are elected and qualify. They also approved the ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, supported by 459,883,831 votes. In addition, stockholders approved on a non-binding, advisory basis the compensation of named executive officers and approved the Second Amended and Restated 2019 Equity Incentive Plan.
Medical Properties Trust reported stronger results for the quarter ended March 31, 2026. Net income was $33.1 million versus a net loss of $118.0 million a year earlier, with revenue rising to $252.1 million from $223.8 million. Earnings per share improved to $0.05 from a loss of $0.20, helped by lower impairment charges, smaller fair value losses, and a one‑time $43 million U.K. deferred tax benefit after moving more entities into the U.K. REIT.
Total assets were $14.8 billion and debt was $9.8 billion, with cash and restricted cash of $428.0 million. Operating cash flow was modestly negative at $(14.3) million as the REIT continued portfolio recycling, including about $31 million of asset sales and new development spending. Exposure to Prospect was reduced to roughly $61 million following asset sales and write‑offs, while re‑tenanting of former Steward and Prospect facilities continued, with new operators ramping toward full contractual rent through October 2026. The company maintained its quarterly dividend at $0.09 per share and remained in compliance with all debt covenants.
Medical Properties Trust, Inc. reported a return to profitability in the first quarter of 2026. Net income attributable to common stockholders was $32.8 million, or $0.05 per share, compared with a net loss of $118.3 million, or $(0.20) per share, a year earlier.
Total revenues rose to $252.1 million from $223.8 million, while normalized funds from operations held steady at $82.2 million, or $0.14 per share. The REIT ended the quarter with approximately $14.8 billion in total assets, a portfolio of 378 properties and about 38,000 licensed beds across nine countries. Management highlighted ramping rent payments at transitioned hospitals and reiterated confidence in collecting at least $1 billion in annualized cash rent by year-end and in addressing upcoming debt maturities.